Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases
CA 2513077 A1 · Owner: Bdd Berolina Drug Development Gmbh · Inventors: Alken, Rudolf-Giesbert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of L-DOPA the derivatives or , pharmacologically-acceptable salts thereof for the prophylaxis of psychotic diseases and for the treatment of diseases caused by disturbed tyrosine transport or disturbed tyrosine decarboxylase. The invention further relates to pharmaceutical compositions which contain L-DOPA the derivatives or , pharmacologically-acceptable salts thereof for the prophylaxis of psychotic diseases along with pharmacologically-acceptable auxiliaries and adjuncts and furthermore, the combination of L-DOPA the derivatives or pharmacologically-, acceptable salts thereof with enzyme inhibitors for the prophylaxis of psychotic diseases and for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 18, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.